|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 49/00 | |
| G01N 33/84 | |||
| A61K 31/192 | |||
| A61K 31/25 | |||
| A61K 31/216 |
| (11) | Patento numeris | 3013372 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15803069.2 |
| Europos patento paraiškos padavimo data | 2015-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/033700 |
| Data | 2015-06-02 |
| (87) | Numeris | WO 2015/187641 |
| Data | 2015-12-10 |
| (30) | Numeris | Data | Šalis |
| 201462007894 P | 2014-06-04 | US |
| (72) |
SCHARSCHMIDT, Bruce, US
MOKHTARANI, Masoud, US
|
| (73) |
Immedica Pharma AB,
Norrtullsgatan 15, 113 29 Stockholm,
SE
|
| (54) | METHODS FOR TREATING UREA CYCLE DISORDERS TO PREVENT HYPERAMMONEMIC CRISES BY CONTROLLING BLOOD AMMONIA LEVELS |
| METHODS FOR TREATING UREA CYCLE DISORDERS TO PREVENT HYPERAMMONEMIC CRISES BY CONTROLLING BLOOD AMMONIA LEVELS |